• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Avidity Biosciences Inc (NQ: RNA )

    44.75 +1.90 (+4.43%)
    Streaming Delayed Price Updated: 9:53 AM EDT, Aug 15, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 707,344
    Open 44.00
    Bid (Size) 44.67 (3)
    Ask (Size) 44.85 (2)
    Prev. Close 42.85
    Today's Range 44.00 - 45.20
    52wk Range 4.825 - 48.80
    Shares Outstanding 54,462,518
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The Analyst Landscape: 7 Takes On Avidity Biosciences
    Via Benzinga
    RNA Stock Earnings: Avidity Biosciences Beats EPS, Misses Revenue for Q2 2024
    RNA stock results show that Avidity Biosciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    +388.54%
    +388.54%
    1 Month
    -1.91%
    -1.91%
    3 Month
    +51.64%
    +51.64%
    6 Month
    +231.24%
    +231.24%
    1 Year
    +415.55%
    +415.55%

    More News

    Read More
    Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    How Avidity Biosciences Just Dropped The Hammer On Sarepta Therapeutics
    Via Investor's Business Daily
    3 Stocks Doing Even Better Than Superstar Super Micro (SMCI)
    Via InvestorPlace
    (RNA) - Analyzing Avidity Biosciences's Short Interest
    Via Benzinga
    Chart Of The Day: Avidity Biosciences - Something's Up?
    Via Talk Markets
    A Glimpse Into The Expert Outlook On Avidity Biosciences Through 6 Analysts
    Via Benzinga
    3 Russell 2000 Growth Stocks That Could Be Worth the Risk
    Via The Motley Fool
    Topics Economy
    Exposures Interest Rates
    GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing
    Via Benzinga
    Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
    Via Benzinga
    Topics ETFs
    Trading SMID Biotech Stocks In A Volatile Market
    Via Talk Markets
    Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
    Via Benzinga
    Adobe, Avidity Biosciences And 3 Stocks To Watch Heading Into Friday
    Via Benzinga
    Crude Oil Moves Higher; Vera Bradley Shares Slide
    Via Benzinga
    Exposures Fossil Fuels
    Why Streamline Health Solutions Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Nasdaq Jumps 300 Points; Oracle Shares Spike Higher
    Via Benzinga
    Why Avidity Biosciences Shares Are Trading Higher Wednesday
    Via Benzinga
    Casey's Reports Upbeat Earnings, Joins Avidity Biosciences, Rentokil Initial And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    The 'Impressive' Results That Sent Top 1% Avidity Biosciences To A High Point
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    2 Potentially High-Reward Growth Stocks to Buy Right Now
    Via The Motley Fool
    Dip Then Rip? 3 Nasdaq Stocks to Buy Before the Rebound
    Via InvestorPlace
    RNA Stock Earnings: Avidity Biosciences Misses EPS, Beats Revenue for Q1 2024
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.